Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07521241
PHASE1
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
Sponsor: Addpharma Inc.
View on ClinicalTrials.gov
Summary
A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
Official title: A Randomized, Open-label, Two-treatment, Two-period, Two-sequence Crossover Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults
Key Details
Gender
All
Age Range
19 Years - 64 Years
Study Type
INTERVENTIONAL
Enrollment
52
Start Date
2026-05
Completion Date
2026-07
Last Updated
2026-04-09
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
AD-230, AD-2301
Oral administration of AD-230 or AD-2301, according to randomized sequence.
Locations (1)
Kyungpook National university hospital
Seoul, South Korea